everion & augment: a window to my health
TRANSCRIPT
Nokia Sensing XChallengeAward Winner 2014
Best medical Wearable Award Winner 2015
Awarded EU's ´Best eHealth SMEs´ 2013
Most innovative Medical Device Company 2015
Preview of the future of digital health 2015
Winner Red Herring Top 100 Europe 2016
Deal of the Year Winner 2016
Everion & Augment: A window to my healthBorn in the cloud - The new generation of integrated hybrid medical monitoring
December 2017 2Proprietary Information Biovotion
99.8% of our lives take place outside the hospital or physician’s office
December 2017 3Proprietary Information Biovotion
The medical reality
14’000 diseases
6’000 drugs
4’000 medical procedures
There is no other industry that deals with so many ‘production lines’ – digitalisation to further scale or even maintain is needed.
December 2017 4Proprietary Information Biovotion
How are you?A simple question and yet so difficult to answer objectively
RWEDecember 2017 Proprietary Information Biovotion 5Proprietary Information Biovotion
December 2017 6Proprietary Information Biovotion
Facts don’t age
Hakim AA et al. NEJM 1998;338:94 Studenski S et al. JAMA 2011;305[1]:50-58
The longer you walk the longer you live Gait speed predicts mortality (>65)
December 2017 7Proprietary Information Biovotion
Impulse response function or speed of HR recovery - SitStand protocol is predictive
• Longitudinal study in ≥50y, n=4475, mean follow up 4.3y
• B2B HR response to 2min standing. HRR by age group, CVD, mortality status
• Speed of HRR is a strong predictor of mortality– A 1 bpm slower HRR from 10 and 20s after standing increased the hazard of
mortality by 6%– 69 in slowest HRR quartile died during observation compared with 14 in fastest
Slowest recovery 2.3× more likely to die
McCrory et al. (2016). Speed of Heart Rate Recovery in Response to Orthostatic Challenge.Circulation Research, 119(5), 666-675.
RWEDecember 2017 Proprietary Information Biovotion 8Proprietary Information Biovotion
Motion tolerant, high resolution &
long term use
EverionNo buttons, no calibration, no tape, no cables
Ultimate ease of use - robust, accurate, versatile
December 2017 9Proprietary Information Biovotion
Medical device class 2aFDA 510(k) exempt listed
Heart rateBlood oxygenation*Skin temperatureSkin blood perfusionSteps/Motion
Everion 1
Stress, multiple HS
Respiratory rate*
HRV & IBI*
Energy expenditureBlood pulse wave
Sweat
Glucose trend
Sleep
Cutaneous waterEverion 2
Everion 3
Parameters
Everion to offer fully integrated multi parametric platform to unfold step by step.
Fully maintains user interface, handling, use and appearance of device over time. December 2017 10Proprietary Information Biovotion
* Limited (yet) motion-tolerant Everion calculates a total of 22 parameters and features
December 2017 11Proprietary Information Biovotion
The user experience
December 2017 12Proprietary Information Biovotion
Ecosystem & Analytics
• mIoT platform• Cyber secured, HIPAA,
GDPR • Rapidly cycle/role out
automated updates• CEK/ML personalized
health insights• Open for 3rd party
innovation and services
December 2017 13Proprietary Information Biovotion
4 types of health action influence health state
Eat , drinkSocialiseHygiene (Bowels)
Nurture
Take medicationMeasure somethingAlert clinician
Medicate
Avoid chronicsedentariness,
stress andinappropriate
eating & diet
ShuffleWalkExercise
Be active
Genetic predispositionEnvironmental effectGenetics
Don’t be activeRest , meditateSleep
Relax
December 2017 14Proprietary Information Biovotion
Accurate and motion tolerant
Easy to use and empowering
Allows day and night use
Connected, cybersecured, GDPR
CEK, ML & AI
Elements of solutions and the B2B2C dogma
Kreuzstr. 2 | 8008 Zurich | Switzerland | www.biovotion.com | [email protected]
Perfection is attained when there is nothing more to be taken awayAntoine de Saint Exupéry
Basic Copyright Notice & Disclaimer
©2017 This presentation is copyright protected. All rights reserved. You may download or print out a hard copy for your private or internal use. You are not permitted to create any modifications or derivatives of this presentation without the prior written permission of the copyright owner.
This presentation is for information purposes only and contains non-binding indications. Any opinions or views expressed are of the author and do not necessarily represent those of Swiss Re. Swiss Re makes no warranties or representations as to the accuracy, comprehensiveness, timeliness or suitability of this presentation for a particular purpose. Anyone shall at its own risk interpret and employ this presentation without relying on it in isolation. In no event will Swiss Re be liable for any loss or damages of any kind, including any direct, indirect or consequential damages, arising out of or in connection with the use of this presentation.